Managers / Q4 2022
Telemetry Investments, L.L.C.
CIK 0001537055 · 152 WEST 36TH STREET, ROOM 402, NEW YORK, NY, 10018-8765 · 212-425-9700
Reported Value
Under review
reported total failed a data-quality check
Positions
146
Filings on Record
17
2019–present window
Filed
Feb 14, 2023
original filing
Summary
Compared with Q3 2022, the fund opened 44 new positions and exited 74.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 34.7% · $22M
- ETP · 33.5% · $21M
- Other · 28.2% · $18M
- REIT · 2.0% · $1M
- ADR · 1.3% · $834,000
- Other · 0.3% · $172,000
Quarter-over-Quarter Changes full breakdown →
vs Q3 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| QQQINVESCO QQQ TR | NEW | +30.0K | 30.0K | +$8M | $8M |
| BKLNINVESCO EXCH TRADED FD TR II | NEW | +50.0K | 50.0K | +$1M | $1M |
| STORE CAP CORP | NEW | +31.5K | 31.5K | +$1M | $1M |
| IMAGO BIOSCIENCES INC | NEW | +19.3K | 19.3K | +$694,000 | $694,000 |
| ATLAS CORP | NEW | +40.8K | 40.8K | +$625,000 | $625,000 |
| POSHMARK INC | NEW | +31.7K | 31.7K | +$567,000 | $567,000 |
| EVO PMTS INC | NEW | +16.5K | 16.5K | +$558,000 | $558,000 |
| IROBOT CORP | NEW | +9.3K | 9.3K | +$449,000 | $449,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2022
132 positions
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | SILVER SPIKE ACQUISITN CORP | CLASS A ORD SHS · *W EXP 02/26/202 | 4.47% | $3M | 336.2K |
| 2 | ACTIVISION BLIZZARD INC | COM | 3.14% | $2M | 26.0K |
| 3 | ATYRATYR PHARMA INChistory → | COM NEW | 2.16% | $1M | 624.0K |
| 4 | TRAJECTORY ALPHA ACQUISITION | COM CL A · *W EXP 99/99/999 | 1.69% | $1M | 159.0K |
| 5 | SHUAA PARTNERS ACQUISTN CORP | UNIT 02/24/2027 | 1.62% | $1M | 100.0K |
| 6 | HOME PLATE ACQUISITION CORP | CL A COM · *W EXP 09/30/202 | 1.60% | $1M | 148.4K |
| 7 | STORE CAP CORP | COM | 1.59% | $1M | 31.5K |
| 8 | AMRYT PHARMA PLC | SPONSORED ADS | 1.50% | $951,000 | 130.3K |
| 9 | BATTERY FUTURE ACQUISITION C | CL A ORD SHS · *W EXP 99/99/999 | 1.45% | $920,000 | 133.9K |
| 10 | MONEYGRAM INTL INC | COM NEW | 1.45% | $917,000 | 84.2K |
| 11 | PARATEK PHARMACEUTICALS INC | COM | 1.43% | $903,000 | 483.0K |
| 12 | VRAYQVIEWRAY INChistory → | COM | 1.42% | $896,000 | 200.0K |
| 13 | HEALTHCARE AI ACQUISITION CO | CLASS A ORD SHS · *W EXP 99/99/999 | 1.36% | $861,000 | 125.8K |
| 14 | SHARECARE INC | COM CL A | 1.26% | $800,000 | 500.0K |
| 15 | HEALTHWELL ACQUISITION CORP | CLASS A COM · *W EXP 08/05/202 | 1.23% | $779,000 | 127.9K |
| 16 | PORTWSOUTHPORT ACQUISITION CORP | CL A COM · *W EXP 99/99/999 | 1.13% | $714,000 | 105.0K |
| 17 | FAST ACQUISITION CORP II | CL A | 1.10% | $695,000 | 69.4K |
| 18 | IMAGO BIOSCIENCES INC | COM | 1.10% | $694,000 | 19.3K |
| 19 | SPIRIT AIRLS INC | COM | 1.08% | $686,000 | 35.2K |
| 20 | BIOPLUS ACQUISITION CORP | CLASS A ORD SHS · *W EXP 12/02/202 | 1.08% | $685,000 | 99.9K |
| 21 | VALUENCE MERGER CORP I | UNIT 02/18/2027 | 1.07% | $677,000 | 65.0K |
| 22 | MERIDIAN BIOSCIENCE INC | COM | 1.06% | $674,000 | 20.3K |
| 23 | ATLAS CORP | SHARES | 0.99% | $625,000 | 40.8K |
| 24 | GRAF ACQUISITION CORP IV | COM | 0.94% | $593,000 | 59.6K |
| 25 | SIMOSILICON MOTION TECHNOLOGY CO | SPONSORED ADR | 0.90% | $567,000 | 8.7K |
| 26 | POSHMARK INC | COM CL A | 0.90% | $567,000 | 31.7K |
| 27 | EVO PMTS INC | CL A COM | 0.88% | $558,000 | 16.5K |
| 28 | AAALCOA CORP | COM | 0.83% | $523,000 | 11.5K |
| 29 | RIGEL PHARMACEUTICALS INC | COM NEW | 0.76% | $484,000 | 322.5K |
| 30 | TSEMTOWER SEMICONDUCTOR LTD | SHS NEW | 0.76% | $480,000 | 11.1K |
| 31 | IROBOT CORP | COM | 0.71% | $449,000 | 9.3K |
| 32 | OXYOCCIDENTAL PETE CORP | COM | 0.70% | $442,000 | 7.0K |
| 33 | ESPRESPERION THERAPEUTICS INC NE | COM | 0.70% | $442,000 | 71.0K |
| 34 | VMWARE INC | CL A COM | 0.69% | $436,000 | 3.5K |
| 35 | ASSERTIO HOLDINGS INC | COM NEW | 0.68% | $430,000 | 100.0K |
| 36 | TGNATEGNA INC | COM | 0.67% | $422,000 | 19.9K |
| 37 | INTELLIGENT MEDI ACQSITN COR | UNIT 11/05/2026 | 0.66% | $418,000 | 40.8K |
| 38 | FCXFREEPORT-MCMORAN INC | CL B | 0.66% | $418,000 | 11.0K |
| 39 | EIGER BIOPHARMACEUTICALS INC | COM | 0.64% | $407,000 | 345.0K |
| 40 | GLDSPDR GOLD TR | GOLD SHS | 0.62% | $390,000 | 2.3K |
| 41 | GANXGAIN THERAPEUTICS INC | COM | 0.61% | $385,000 | 123.0K |
| 42 | UMPQUA HLDGS CORP | COM | 0.57% | $363,000 | 20.4K |
| 43 | GRITSTONE BIO INC | COM | 0.57% | $362,000 | 105.0K |
| 44 | BLACK KNIGHT INC | COM | 0.57% | $358,000 | 5.8K |
| 45 | MSOSADVISORSHARES TR | PURE US CANNABIS | 0.55% | $350,000 | 50.0K |
| 46 | GLOBALSTAR INC | COM | 0.53% | $336,000 | 252.5K |
| 47 | CRVSCORVUS PHARMACEUTICALS INC | COM | 0.52% | $332,000 | 390.0K |
| 48 | POWERUP ACQUISITION CORP | UNIT 02/18/2032 | 0.51% | $320,000 | 31.0K |
| 49 | CCITIGROUP INC | COM NEW | 0.50% | $317,000 | 7.0K |
| 50 | MSFTMICROSOFT CORP | COM | 0.49% | $313,000 | 1.3K |
| 51 | ACIALBERTSONS COS INC | COMMON STOCK | 0.49% | $311,000 | 15.0K |
| 52 | NBRNABORS INDUSTRIES LTD | SHS | 0.49% | $310,000 | 2.0K |
| 53 | PRTAPROTHENA CORP PLC | SHS | 0.48% | $301,000 | 5.0K |
| 54 | 1LIFE HEALTHCARE INC | COM | 0.46% | $294,000 | 17.6K |
| 55 | SOUTH JERSEY INDS INC | COM | 0.46% | $291,000 | 8.2K |
| 56 | BENEFITFOCUS INC | COM | 0.45% | $283,000 | 27.1K |
| 57 | VACCINEX INC | COM | 0.42% | $268,000 | 416.0K |
| 58 | BABYLON HLDGS LTD | CL A SHS | 0.42% | $267,000 | 39.5K |
| 59 | CARTESIAN GROWTH CORP II | UNIT 07/12/2028 | 0.40% | $256,000 | 25.0K |
| 60 | AFFIMED N V | COM | 0.39% | $248,000 | 200.0K |
| 61 | RAPT THERAPEUTICS INC | COM | 0.38% | $238,000 | 12.0K |
| 62 | PLDPROLOGIS INC. | COM | 0.37% | $237,000 | 2.1K |
| 63 | DENBURY INC | COM | 0.37% | $235,000 | 2.7K |
| 64 | EURONAV NV | SHS | 0.36% | $228,000 | 13.4K |
| 65 | BIIBBIOGEN INC | COM | 0.36% | $226,000 | 817 |
| 66 | ADMAADMA BIOLOGICS INC | COM | 0.35% | $223,000 | 57.5K |
| 67 | MIND MEDICINE MINDMED INC | COM NEW | 0.33% | $211,000 | 96.0K |
| 68 | RIVNRIVIAN AUTOMOTIVE INC | COM CL A | 0.33% | $209,000 | 11.3K |
| 69 | XYZBLOCK INC | CL A | 0.33% | $207,000 | 3.3K |
| 70 | ADICET BIO INC | COM | 0.30% | $192,000 | 21.5K |
| 71 | ARDXARDELYX INC | COM | 0.30% | $191,000 | 67.0K |
| 72 | NVAXNOVAVAX INC | COM NEW | 0.29% | $181,000 | 17.6K |
| 73 | AMPYAMPLIFY ENERGY CORP NEW | COM | 0.29% | $181,000 | 20.6K |
| 74 | USERTESTING INC | COM | 0.28% | $180,000 | 24.0K |
| 75 | CNKCINEMARK HLDGS INC | COM | 0.27% | $171,000 | 19.7K |
| 76 | FUTURE HEALTH ESG CORP | COM · *W EXP 99/99/999 | 0.25% | $158,000 | 164.5K |
| 77 | MUSTANG BIO INC | COM | 0.24% | $155,000 | 392.7K |
| 78 | GAPGAP INC | COM | 0.24% | $153,000 | 13.6K |
| 79 | TRACON PHARMACEUTICALS INC | COM NEW | 0.23% | $145,000 | 97.0K |
| 80 | APPAPPLOVIN CORP | COM CL A | 0.22% | $139,000 | 13.2K |
| 81 | BTXBLACKROCK INNOVATION AND GRW | SHS BEN INT | 0.21% | $136,000 | 19.9K |
| 82 | DBRGDIGITALBRIDGE GROUP INC | CL A NEW | 0.21% | $133,000 | 12.2K |
| 83 | PTONPELOTON INTERACTIVE INC | CL A COM | 0.21% | $130,000 | 16.4K |
| 84 | ECECOPETROL S A | SPONSORED ADS | 0.19% | $118,000 | 11.3K |
| 85 | ACORDA THERAPEUTICS INC | COM NEW | 0.16% | $102,000 | 132.5K |
| 86 | KORE GROUP HLDGS INC | COMMON STOCK · *W EXP 09/30/202 | 0.15% | $97,000 | 183.0K |
| 87 | FRESH TRACKS THERAPEUTICS IN | COM NEW | 0.15% | $95,000 | 65.0K |
| 88 | VERASTEM INC | COM | 0.14% | $91,000 | 225.0K |
| 89 | UMCUNITED MICROELECTRONICS CORP | SPON ADR NEW | 0.13% | $81,000 | 12.3K |
| 90 | AGROFRESH SOLUTIONS INC | COM | 0.12% | $75,000 | 25.2K |
| 91 | ELEVATE CREDIT INC | COM | 0.11% | $69,000 | 39.4K |
| 92 | EVAXION BIOTECH A S | ADS | 0.11% | $68,000 | 37.5K |
| 93 | HARPOON THERAPEUTICS INC | COM | 0.11% | $67,000 | 93.0K |
| 94 | APTOSE BIOSCIENCES INC | COM NEW | 0.09% | $58,000 | 100.0K |
| 95 | MARIADB PLC | ORD SHS · *W EXP 12/16/202 | 0.09% | $58,000 | 46.4K |
| 96 | HUMANIGEN INC | COM NEW | 0.09% | $56,000 | 470.0K |
| 97 | ALLOT LTD | SHS | 0.08% | $53,000 | 15.5K |
| 98 | CHECKPOINT THERAPEUTICS INC | COM NEW | 0.08% | $51,000 | 10.0K |
| 99 | VASCULAR BIOGENICS LTD | COM | 0.08% | $48,000 | 403.5K |
| 100 | FORTRESS BIOTECH INC | COM | 0.07% | $47,000 | 72.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q4 2022 | Under review | 146 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $78M | 177 | Nov 17, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $84M | 177 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $63M | 165 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $78M | 178 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $74M | 160 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $73M | 139 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $88M | 126 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $59M | 89 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $46M | 73 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $37M | 65 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $29M | 54 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $30M | 41 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $35M | 53 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $129M | 82 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $197M | 101 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $157M | 136 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.